News
Latest News and Press Releases
A Co-authored Paper regarding Immunocompromised type 1 Diabetic Mini-pigs was Published in the Cell Transplantation
Xenogenic Engraftment of Human Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-pig...
Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals
September 10, 2024 - Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as...
Axcelead DDP and Lilly Enter into A Research and Collaboration Agreement
September 5, 2024 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today...
Axcelead DDP has become a certified provider of Single Cell Gene Expression Solution, from 10x Genomics
We’re delighted to announce that Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) has received official certification from...
Achieved the First Milestone in Drug Discovery Support to Otsuka Pharmaceutical
May 27, 2024 – Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa-city, Kanagawa; “Axcelead DDP”) announces that the first...